U.S. markets closed

Olema Pharmaceuticals, Inc. (OLMA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
35.86+3.38 (+10.41%)
At close: 4:00PM EDT

35.86 0.00 (0.00%)
After hours: 4:00PM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/12/2021
Current
12/31/2020
Market Cap (intraday) 5
1.29B1.93B
Enterprise Value 3
952.33M1.80B
Trailing P/E
N/AN/A
Forward P/E 1
N/AN/A
PEG Ratio (5 yr expected) 1
N/AN/A
Price/Sales (ttm)
N/AN/A
Price/Book (mrq)
3.8215.07
Enterprise Value/Revenue 3
N/AN/A
Enterprise Value/EBITDA 7
-44.38-178.09

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-33.71%
S&P500 52-Week Change 348.80%
52 Week High 360.27
52 Week Low 326.74
50-Day Moving Average 337.97
200-Day Moving Average 343.21

Share Statistics

Avg Vol (3 month) 3158.77k
Avg Vol (10 day) 3106.04k
Shares Outstanding 539.31M
Implied Shares Outstanding 6N/A
Float 19.04M
% Held by Insiders 19.64%
% Held by Institutions 187.57%
Shares Short (Mar 30, 2021) 4860.99k
Short Ratio (Mar 30, 2021) 43.35
Short % of Float (Mar 30, 2021) 43.24%
Short % of Shares Outstanding (Mar 30, 2021) 42.19%
Shares Short (prior month Feb 25, 2021) 4463.28k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-7.85%
Return on Equity (ttm)-13.13%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.52M
Net Income Avi to Common (ttm)-23.99M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)338.55M
Total Cash Per Share (mrq)8.59
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)74.62
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-19.87M
Levered Free Cash Flow (ttm)-11.15M